PROCEPT BioRobotics Corp (PRCT)
68.14
-1.05
(-1.52%)
USD |
NASDAQ |
May 16, 16:00
68.69
+0.55
(+0.81%)
After-Hours: 20:00
PROCEPT BioRobotics Cash from Investing (Quarterly): -1.946M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -1.946M |
| December 31, 2023 | -8.715M |
| September 30, 2023 | -5.78M |
| June 30, 2023 | -5.372M |
| March 31, 2023 | -5.339M |
| December 31, 2022 | -0.866M |
| September 30, 2022 | -1.514M |
| Date | Value |
|---|---|
| June 30, 2022 | -0.218M |
| March 31, 2022 | -0.055M |
| December 31, 2021 | -0.332M |
| September 30, 2021 | -0.111M |
| June 30, 2021 | -0.11M |
| March 31, 2021 | -0.039M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-8.715M
Minimum
Dec 2023
-0.039M
Maximum
Mar 2021
-2.338M
Average
-0.866M
Median
Dec 2022
Cash from Investing (Quarterly) Benchmarks
| Globus Medical Inc | -46.58M |
| Glaukos Corp | -29.38M |
| Integra Lifesciences Holdings Corp | -53.96M |
| Intuitive Surgical Inc | -128.50M |
| Masimo Corp | -18.90M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -32.29M |
| Cash from Financing (Quarterly) | 2.586M |
| Free Cash Flow | -126.17M |
| Free Cash Flow Per Share (Quarterly) | -0.6711 |
| Free Cash Flow to Equity (Quarterly) | -34.26M |
| Free Cash Flow Yield | -3.80% |